Strengthening physiotherapy through digitalization and networking

Now, with the Unit­ed Ther­a­py Group, a strong provider in the Ger­man phys­io­ther­a­py mar­ket is cre­at­ed. For this merg­er, Quadri­ga Cap­i­tal Funds (“Quadri­ga Cap­i­tal”), Lux­em­part S.A., Deutsche Arzt AG and NOVO‑T AG signed a cor­re­spond­ing agree­ment on Feb­ru­ary 28, 2022. The aim of the group is to cre­ate an ecosys­tem by inno­v­a­tive­ly com­bin­ing ana­log phys­io­ther­a­py with dig­i­tal telemed­i­cine offer­ings. To this end, the man­age­ment team around CEO Jochen Roeser aims to dri­ve new net­worked and holis­tic care solu­tions in the health­care market.

As a new share­hold­er, Quadri­ga Cap­i­tal sup­ports the Group’s growth with its in-depth exper­tise in the trans­for­ma­tion of health­care com­pa­nies. NOVO‑T AG brings its sub­sidiary NOVOTERGUM GmbH, one of the lead­ing phys­io­ther­a­py chains with over 50 loca­tions in Ger­many, into the merg­er. Deutsche Arzt AG con­tributes its inno­v­a­tive dig­i­tal app-based solu­tions for ther­a­py man­age­ment and pre­ven­tion, as well as its health insur­ance direct con­tracts and nation­al ortho­pe­dic care net­work. Lux­em­part S.A. is leav­ing the share­hold­er group after three years of suc­cess­ful support.

“To devel­op phys­io­ther­a­py into a com­plete­ly new dimen­sion — that is our joint goal. The merg­er of lead­ing com­pa­nies from the Ger­man ther­a­py mar­ket and the con­sis­tent inte­gra­tion of dig­i­tal health offer­ings under the new umbrel­la Unit­ed Ther­a­py is a deci­sive step towards the phys­io­ther­a­py of the future. We want to lever­age pre­vi­ous­ly untapped poten­tial of med­ical move­ment through dig­i­tal­iza­tion and net­work­ing. This is a cen­tral key for sus­tain­able ther­a­pies with­out side effects and serves as pre­ven­tion for most major com­mon dis­eases. We are pleased to have now found a part­ner who is high­ly expe­ri­enced in the health­care sec­tor and who can effec­tive­ly sup­port us in achiev­ing our goals. This will enable us to grow strong­ly in the future by adding fur­ther phys­io­ther­a­py cen­ters. This will also open up new per­spec­tives for our cur­rent work­force of over 600 employees.”

- Jochen Roeser

“Unit­ed Ther­a­py is already a lead­ing phys­io­ther­a­py provider in Ger­many. The com­pa­ny will con­tin­ue to devel­op this mar­ket in the inter­ests of patients and pay­ers. There­fore, we are very much look­ing for­ward to work­ing with the vision­ary and high­ly moti­vat­ed man­age­ment team,” says Dr. Philip Mat­la­chowsky, Part­ner of Quadri­ga Cap­i­tal Eigenkap­i­tal­ber­atung GmbH, which advis­es Quadri­ga Cap­i­tal Funds in Lux­em­bourg and Jer­sey. “We want to use our exten­sive knowl­edge of fast-grow­ing health­care plat­forms to sup­port the team in writ­ing this suc­cess sto­ry,” Mat­la­chowsky said.